IL23R and inflammatory bowel disease: Strong evidence for this common mechanism comes both from the elevated expression of IL-17 and IL-23 in the gut mucosa of active UC and CD patients compared to healthy controls and from genome-wide association studies linking single nucleotide polymorphisms (SNPs) in the IL-23 receptors (IL-23R) and in STAT3 to an increased risk for IBD [24,25].